Growth Failure

DrugDrug NameDrug Description
DB16220LonapegsomatropinA human growth hormone indicated in the treatment of growth failure due to inadequate endogenous growth hormone secretion.
DB14751Mecasermin rinfabateMecasermin rinfabate was approved for treatment of severe primary insulin-like growth factor (IGF) deficiency or in patients with GH gene deletion who have developed antibodies to growth hormone (GH) ....
DB00052SomatotropinA recombinant human growth hormone used as replacement therapy in various conditions of growth failure, growth hormone deficiency, and weakness in children and adults.
DB14960SomatrogonA long-acting recombinant human growth hormone used as the long-term treatment of pediatric patients who have growth failure due to growth hormone deficiency.
DrugDrug NamePhaseStatusCount
DB00936Salicylic acid1Completed1
DB00052Somatotropin1Completed1
DB01277Mecasermin1 / 2Terminated1
DB00052Somatotropin3Recruiting1
DB00125Arginine4Unknown Status1
DB00575Clonidine4Unknown Status1
DB13956Estradiol valerate4Unknown Status1
DB00052Somatotropin4Unknown Status1
DB13961Fish oilNot AvailableAvailable1
DB01277MecaserminNot AvailableWithdrawn1
DB13959Medium-chain triglyceridesNot AvailableAvailable1
DB09567Olive oilNot AvailableAvailable1
DB09422Soybean oilNot AvailableAvailable1